Mutations in the conserved woodchuck hepatitis virus polymerase FLLA and YMDD regions conferring resistance to lamivudine-Reference-Cited by-同舟云学术

Mutations in the conserved woodchuck hepatitis virus polymerase FLLA and YMDD regions conferring resistance to lamivudine

Published:2002-07 Issue:1 Volume:55 Page:141-150
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Tatti Kathleen M.,Korba Brent E.,Stang Heather L.,Peek Simon,Gerin John L.,Tennant Bud C.,Schinazi Raymond F.

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference38 articles.

1. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine;Allen;Hepatology,1998

2. Hepatitis B virus mutations during antiviral therapy in a patient following liver transplantation;Aye;J. Hepatol.,1997

3. Clinical experience with famciclovir against hepatitis B virus;Bartholomeuw;Intervirology,1997

4. Hepatitis B virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation;Bartholomeuw;Lancet,1997

5. Significance of mutations in the hepatitis B virus polymerase selected by nucleoside analogues and implications for controlling chronic disease;Bartholomeuw;Viral Hep. Rev.,1998

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of the woodchuck animal model for the treatment of hepatitis B virus-induced liver cancer;World Journal of Gastrointestinal Oncology;2021-06-15

2. Hepatitis B Virus Gene Mutations in Liver Diseases: A Report from New Delhi;PLoS ONE;2012-06-14

3. Mechanistic Characterization and Molecular Modeling of Hepatitis B Virus Polymerase Resistance to Entecavir;PLoS ONE;2010-02-12

4. Hepatitis B Viral Surface Mutations in Patients with Adefovir Resistant Chronic Hepatitis B with A181T/V Polymerase Mutations;Journal of Korean Medical Science;2010

5. Genotypic determinants and phenotypic properties of antiviral-resistant HBV variants: insight from entecavir resistance studies;Antiviral Therapy;2010